Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Valeria Santini et al.|Nature Medicine|2020Cited by 633
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Marie Robin et al.|Journal of Clinical Oncology|2023Cited by 109
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Gastone Castellani, Manja Meggendorfer et al.|Blood|2021Cited by 72
A framework for the clinical implementation of optical genome mapping in hematologic malignanciesBrynn Levy, Adam C. Smith, Rashmi Kanagal‐Shamanna et al.|American Journal of Hematology|2024Cited by 49
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Olivier Nibourel, Caterina Gregorio et al.|Journal of Clinical Oncology|2024Cited by 39